Reports of Long Covid diagnoses and symptoms in patients have dropped since the beginning of the pandemic. The percentage of people who have had COVID and currently report long COVID symptoms declined from 19% in June 2022 to 11% in January 2023. That decrease reflects a reduction in the share of people who have COVID and later report long COVID, which declined from 35% to 28% during the same period.
With the roll-out of vaccines, a significant portion of the population has been vaccinated which has reduced the number of new COVID-19 cases and hospitalizations. Currently, 81% of the U.S. population has received at least one vaccine for COVID-19. Vaccines have been shown to reduce the severity of COVID-19 symptoms and the risk of Long Covid. Also, increased population immunity through vaccines and prior infections may be reducing these numbers. Some of the reasons for this involve improved treatment, changes in virus variants and more awareness.
Since the beginning of the pandemic, healthcare providers have gained a better understanding of COVID-19 and have developed new treatments that can reduce the severity of symptoms and the risk of Long COVID. For example, the use of steroids and antiviral medications has been shown to be effective in treating COVID-19.